NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE ADVANCED Test
Test Name: NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE ADVANCED Test
Components: Amphiphysin, CV2, PNMA2(Ma2/Ta), ANNA-1/Hu, ANNA-2/Ri, PCA-1/Yo, SOX1, Titin, Recoverin
Price: 2460.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery: Sample Mon through Sat by 9am; Report Same day
Method: Immunoblot
Test type: Paraneoplastic Syndromes
Doctor: Oncologist
Test Department:
Pre Test Information: No special preparation required
Test Details:
The Neuronal (Paraneoplastic) Autoantibodies Profile Advanced Test is a diagnostic test used to detect the presence of autoantibodies in the blood that are associated with paraneoplastic neurological disorders. These disorders are a group of rare neurological conditions that occur in some individuals with cancer.
The test helps in the diagnosis and management of paraneoplastic neurological disorders by identifying specific autoantibodies that target neurons in the nervous system. These autoantibodies are produced by the immune system in response to an underlying cancer, often a small cell lung cancer or a gynecological tumor.
The Neuronal (Paraneoplastic) Autoantibodies Profile Advanced Test uses various techniques such as immunoblotting and immunohistochemistry to detect the presence of specific autoantibodies. The test can detect autoantibodies against several neuronal antigens, including Hu, Yo, Ri, Ma2/Ta, CV2/CRMP5, and amphiphysin.
The results of the test can help in identifying the specific autoantibodies present, which can then aid in determining the underlying cancer type and guiding treatment decisions. Additionally, the test can also help in differentiating paraneoplastic neurological disorders from other neurological conditions with similar symptoms.
Overall, the Neuronal (Paraneoplastic) Autoantibodies Profile Advanced Test plays a crucial role in the diagnosis and management of paraneoplastic neurological disorders, allowing for early detection and appropriate treatment.
Test Name | NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE ADVANCED Test |
---|---|
Components | *Amphiphysin*CV2*PNMA2(Ma2/Ta) *ANNA-1/Hu*ANNA-2/Ri*PCA-1/Yo *SOX1 *Titin*Recoverin |
Price | 2460.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen.. |
Report Delivery | SampleMon through Sat by 9am;ReportSameday |
Method | Immunoblot |
Test type | Paraneoplastic Syndromes |
Doctor | Oncologist |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The Neuronal (Paraneoplastic) Autoantibodies Profile Advanced Test is a diagnostic test used to detect the presence of autoantibodies in the blood that are associated with paraneoplastic neurological disorders. These disorders are a group of rare neurological conditions that occur in some individuals with cancer. The test helps in the diagnosis and management of paraneoplastic neurological disorders by identifying specific autoantibodies that target neurons in the nervous system. These autoantibodies are produced by the immune system in response to an underlying cancer, often a small cell lung cancer or a gynecological tumor. The Neuronal (Paraneoplastic) Autoantibodies Profile Advanced Test uses various techniques such as immunoblotting and immunohistochemistry to detect the presence of specific autoantibodies. The test can detect autoantibodies against several neuronal antigens, including Hu, Yo, Ri, Ma2/Ta, CV2/CRMP5, and amphiphysin. The results of the test can help in identifying the specific autoantibodies present, which can then aid in determining the underlying cancer type and guiding treatment decisions. Additionally, the test can also help in differentiating paraneoplastic neurological disorders from other neurological conditions with similar symptoms. Overall, the Neuronal (Paraneoplastic) Autoantibodies Profile Advanced Test plays a crucial role in the diagnosis and management of paraneoplastic neurological disorders, allowing for early detection and appropriate treatment. |